Developer docs
API playgroundTry for free, no card

Search company profiles

Gleamer

Full company profile

uuid0000d8s

Namestring
Gleamer
Legal namestring
GLEAMER
Websiteurl
gleamer.ai
Company typeenum
Private
Founded yearint
2017
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiology AI software, medical imaging AI, AI fracture detection, radiology workflow automation, clinical decision support
Industry4 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Radiology AI / Medical Imaging Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscriptions
TypeSubscription Recurring
Description

Annual recurring revenue from SaaS subscriptions to Gleamer Copilot platform and individual AI applications. Customers pay subscription fees for access to AI-powered radiology tools. ARR exceeded $30 million in 2026 prior to acquisition by RadNet, with over 90% CAGR from 2022-2025.

stocktitan.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise subscription pricing for hospitals and imaging groups
ModelSubscriptionBilling cadenceAnnual
Notes

Custom pricing based on institution size, number of radiologists, and number of AI applications deployed. Contact sales for demo and quote.

gleamer.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 13 records shown
1Gleamer Copilot
Description

The all-in-one AI platform for radiology combining detection tools, smart measurements, and structured reporting

gleamer.ai
+12 more records
Core offering1 text field

Gleamer develops and sells AI-powered clinical software for radiologists that detects fractures, chest pathologies, lung nodules, breast lesions, and neurological findings on X-ray, CT, MRI, and mammography images, automates musculoskeletal measurements, and generates structured radiology reports. Its Gleamer Copilot platform unifies these AI applications and integrates them into radiologist PACS/RIS workflows through the GleamerOS orchestration layer.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Missed fractures decreased by 30% with AI assistance
+6 more records
Product overview1 text field

Gleamer is a French medtech company (acquired by RadNet in March 2026) offering Gleamer Copilot, an all-in-one AI platform for radiology covering all major imaging modalities (X-ray, CT, MRI, Mammography). The portfolio comprises 11+ clinical AI applications organized in three tiers: Detection AI (BoneView, ChestView, BreastView, LungCT, BoneCT), Measurement AI (BoneMetrics, BoneAge), and Neuro MRI AI (Pixyl.Neuro.MS, Pixyl.Neuro.BV, LumbarMR). Reporting AI products (Voice, AutoReport) generate structured reports from AI findings. The entire ecosystem runs on GleamerOS, a cloud-native orchestration platform enabling deployment via a single Gateway with deep RIS/PACS integration via DICOM, HL7, and FHIR standards. Products are available as CE-marked (EU) and FDA 510(k)-cleared (US) Class II medical devices.

Product and service13 records
1Gleamer Copilot
CategoryRadiology AI platform
Description

Unified AI platform that combines detection tools, smart measurements, and structured reporting seamlessly integrated into radiologist workflows across X-ray, CT, MRI, and mammography modalities.

2BoneView
CategoryClinical AI application — X-ray bone trauma detection
Description

FDA 510(k)-cleared and CE-marked AI solution that detects fractures, dislocations, bone lesions, and effusions on radiographs with >99% NPV, reducing missed fractures by 30% and reading time by 36%.

3BoneMetrics
CategoryClinical AI application — MSK measurements
Description

FDA-cleared and CE-marked AI solution that automates 50+ musculoskeletal measurements including Cobb angles, HKA angles, leg length, shoulder, knee, and pelvic measurements, with 93.4% of measurements requiring no further adjustments.

4ChestView
CategoryClinical AI application — Chest X-ray pathology detection
Description

FDA-cleared and CE-marked AI solution that detects pneumothorax, consolidation, nodules, mediastinal masses, and pleural effusions on chest X-rays, increasing sensitivity by up to 50% for pneumothorax and reducing missed pneumothorax by 55%.

5BoneAge
CategoryClinical AI application — Pediatric bone age assessment
Description

CE-marked AI solution that automates pediatric bone age assessment from hand X-rays using the Greulich & Pyle atlas method, achieving an MAE of 0.49 years (6 months) versus 0.72 years (9 months) for human readers.

6LungCT
CategoryClinical AI application — CT lung nodule detection
Description

CE-marked AI solution that detects and characterizes pulmonary nodules on chest CT, achieving 43.3% fewer missed nodules versus unaided radiologists and 76% sensitivity for all nodules.

7BoneCT
CategoryClinical AI application — CT bone lesion detection
Description

CE-marked AI solution that detects secondary bone lesions on CT scans for oncology staging, identifying bone metastases on spine, pelvis, and long bones with 67% sensitivity versus 56% for radiologists without AI.

8BreastView
CategoryClinical AI application — Mammography lesion detection
Description

CE-marked AI mammography assistant that analyzes 2D and 3D mammograms to detect soft tissue lesions, masses, distortions, asymmetries, and microcalcifications with 85% sensitivity and 93% specificity for cancer detection.

9Pixyl.Neuro.MS
CategoryClinical AI application — MRI multiple sclerosis detection
Description

FDA-cleared and CE-marked AI solution for multiple sclerosis on brain MRI that automatically detects, categorizes, and quantifies white-matter lesions on 3D FLAIR, with 97% sensitivity for detecting disease activity.

10Pixyl.Neuro.BV
CategoryClinical AI application — MRI brain volumetry
Description

FDA-cleared and CE-marked AI solution that segments brain structures on 3D T1-weighted MRI, computes volumes, compares to a normative population, and highlights atrophy patterns for Alzheimer's disease and other dementias.

11LumbarMR
CategoryClinical AI application — MRI spine pathology
Description

AI solution for lumbar spine MRI that automatically detects and characterizes degenerative findings including endplate degeneration, disc herniation, compression fractures, spondylolisthesis, central canal stenosis, foraminal stenosis, and facet arthropathy.

12Voice
CategoryReporting AI — Voice dictation assistant
Description

AI-powered voice dictation and reporting assistant that listens to radiologist dictation, understands medical context, auto-fills indication, technique, and findings, and proposes smart impressions across custom templates.

13AutoReport
CategoryReporting AI — Automated report generation
Description

AI reporting assistant that automatically generates structured radiology reports with AI findings, key measurements, and smart impressions, compatible with HL7, FHIR, and DICOM SR standards.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-18
Description

Vestre Viken Hospital Trust implemented Philips AI Manager with Philips Vue PACS, deploying Gleamer's BoneView as the first AI solution in routine clinical use. Demonstrates integration capabilities with Philips healthcare IT infrastructure.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-22
Description

Strategic partnership where Google Cloud powers Gleamer's radiological AI platform, Gleamer Copilot. Leverages Google Cloud infrastructure including BigQuery, Vertex AI, and Med-PaLM for automated diagnostic report generation. Platform deployed in 2,500+ institutions across 45 countries processing 35 million examinations annually.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-07-09
Description

Strategic partnership to deploy Gleamer Copilot nationwide across France Imageries Territoires imaging network. Major national deployment expanding Gleamer's presence in French healthcare market.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-12-04
Description

Partnership to provide best-in-class AI-powered solution with Konica Minolta's portfolio of advanced X-ray systems. Combines Gleamer's AI detection capabilities with Konica Minolta's imaging hardware for integrated customer offerings.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-09-06
Description

Gleamer's BoneView available on Siemens Healthineers Digital Marketplace, enabling seamless integration with Siemens Healthineers PACS and imaging systems. Expands distribution through Siemens Healthineers global customer network.

Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2023-08-01
Description

Norway's first hospital trust to integrate Philips AI Manager with Philips Vue PACS, deploying Gleamer's BoneView as first AI solution. Since August 2023, examined 74,000 patients, saving 594 days waiting time, preventing 13,800 emergency consultations, freeing 3,100 physician hours. Sets national blueprint for AI deployment in radiology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Aidoc is a direct competitor offering a comprehensive AI platform for radiology covering multiple modalities and clinical workflows, with FDA-cleared applications across CT, X-ray, and MRI. It targets the same hospital and imaging center buyer base as Gleamer with a similar platform-plus-app strategy.

TypeDirect peer
Description

Qure.ai develops multi-modality radiology AI (chest X-ray, head CT, lung nodule, musculoskeletal) with strong presence in emerging and developed markets. It competes head-to-head with Gleamer in fracture, chest, and head CT detection products sold to hospitals and radiology groups.

TypeDirect peer
Description

Lunit is a publicly-traded Korean radiology AI company known for its chest X-ray (Lunit INSIGHT CXR) and mammography (Lunit INSIGHT MMG) products. It directly competes with Gleamer's ChestView and BreastView in the mammography and chest X-ray detection categories.

TypeDirect peer
Description

Annalise.ai offers a comprehensive AI decision-support platform covering X-ray and CT findings across multiple anatomies, with broad modality coverage that mirrors Gleamer Copilot's horizontal strategy. It serves hospitals and radiology groups globally with a similar product breadth.

TypeBroad incumbent
Description

Siemens Healthineers is both a Gleamer partner (Digital Marketplace) and a competitor via its AI-Rad Companion portfolio, which offers native radiology AI capabilities to its large installed base of imaging systems. It represents a broad incumbent with overlapping capabilities but a much wider portfolio.

TypeBroad incumbent
Description

Philips is both a Gleamer partner (AI Manager integration at Vestre Viken) and a competitor through its broader clinical AI portfolio tied to Vue PACS and imaging systems. It has the scale and distribution to bundle first-party AI offerings alongside Gleamer's solutions.

TypeDirect peer
Description

Viz.ai is a leading AI platform for time-sensitive radiology workflows, particularly stroke and cardiology, selling into the same hospital system buyer base as Gleamer. It represents a strong AI-native peer in adjacent clinical use cases within the radiology AI category.

TypeDirect peer
Description

RapidAI provides AI-driven imaging analysis for stroke, aneurysm, and other time-sensitive conditions, with hospital enterprise sales. It overlaps with Gleamer's MRI/CT product strategy in neurovascular and shares the same hospital radiology buyer.

TypeBroad incumbent
Description

GE HealthCare competes through its Edison AI platform and AI-powered imaging applications integrated with its large installed base of CT, MRI, and X-ray systems. It is a broad incumbent with the scale to bundle or replace third-party AI solutions like Gleamer's.

TypeEmerging player
Description

Riverain Technologies is a focused radiology AI company specializing in chest X-ray interpretation, directly competing with Gleamer's ChestView in the same clinical use case. It is a smaller, more focused player with partial modality overlap.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance12 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gleamer

Radiology AI / Medical Imaging Softwaregleamer.ai

Gleamer firmographics

Firmographics
Name
Gleamer
Legal name
GLEAMER
Website
https://gleamer.ai
Company type
Private
Founded year
2017
Operating status
Acquired
Headcount range
101–250 employees
Ownership category
akta.pro rank

Gleamer industry classification

Industry
Product category
Radiology AI / Medical Imaging Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Radiology AI software
  • Medical imaging AI
  • AI fracture detection
  • Radiology workflow automation
  • Clinical decision support

Where Gleamer is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Gleamer business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. SaaS Subscriptions: Annual recurring revenue from SaaS subscriptions to Gleamer Copilot platform and individual AI applications. Customers pay subscription fees for access to AI-powered radiology tools. ARR exceeded $30 million in 2026 prior to acquisition by RadNet, with over 90% CAGR from 2022-2025.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription pricing for hospitals and imaging groups

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Gleamer product offering

Product offering

Core offering

Gleamer develops and sells AI-powered clinical software for radiologists that detects fractures, chest pathologies, lung nodules, breast lesions, and neurological findings on X-ray, CT, MRI, and mammography images, automates musculoskeletal measurements, and generates structured radiology reports. Its Gleamer Copilot platform unifies these AI applications and integrates them into radiologist PACS/RIS workflows through the GleamerOS orchestration layer.

Product overview

Gleamer is a French medtech company (acquired by RadNet in March 2026) offering Gleamer Copilot, an all-in-one AI platform for radiology covering all major imaging modalities (X-ray, CT, MRI, Mammography). The portfolio comprises 11+ clinical AI applications organized in three tiers: Detection AI (BoneView, ChestView, BreastView, LungCT, BoneCT), Measurement AI (BoneMetrics, BoneAge), and Neuro MRI AI (Pixyl.Neuro.MS, Pixyl.Neuro.BV, LumbarMR). Reporting AI products (Voice, AutoReport) generate structured reports from AI findings. The entire ecosystem runs on GleamerOS, a cloud-native orchestration platform enabling deployment via a single Gateway with deep RIS/PACS integration via DICOM, HL7, and FHIR standards. Products are available as CE-marked (EU) and FDA 510(k)-cleared (US) Class II medical devices.

Differentiator

Problem solved

Functional benefit

Brands

  • Gleamer Copilot: The all-in-one AI platform for radiology combining detection tools, smart measurements, and structured reporting
  • GleamerOS
  • BoneView
  • ChestView
  • BoneMetrics
  • BoneAge
  • LungCT
  • BoneCT
  • BreastView
  • Pixyl.Neuro
  • LumbarMR
  • Voice
  • AutoReport

Products and services

  • Gleamer Copilot Unified AI platform that combines detection tools, smart measurements, and structured reporting seamlessly integrated into radiologist workflows across X-ray, CT, MRI, and mammography modalities.
  • BoneView FDA 510(k)-cleared and CE-marked AI solution that detects fractures, dislocations, bone lesions, and effusions on radiographs with >99% NPV, reducing missed fractures by 30% and reading time by 36%.
  • BoneMetrics FDA-cleared and CE-marked AI solution that automates 50+ musculoskeletal measurements including Cobb angles, HKA angles, leg length, shoulder, knee, and pelvic measurements, with 93.4% of measurements requiring no further adjustments.
  • ChestView FDA-cleared and CE-marked AI solution that detects pneumothorax, consolidation, nodules, mediastinal masses, and pleural effusions on chest X-rays, increasing sensitivity by up to 50% for pneumothorax and reducing missed pneumothorax by 55%.
  • BoneAge CE-marked AI solution that automates pediatric bone age assessment from hand X-rays using the Greulich & Pyle atlas method, achieving an MAE of 0.49 years (6 months) versus 0.72 years (9 months) for human readers.
  • LungCT CE-marked AI solution that detects and characterizes pulmonary nodules on chest CT, achieving 43.3% fewer missed nodules versus unaided radiologists and 76% sensitivity for all nodules.
  • BoneCT CE-marked AI solution that detects secondary bone lesions on CT scans for oncology staging, identifying bone metastases on spine, pelvis, and long bones with 67% sensitivity versus 56% for radiologists without AI.
  • BreastView CE-marked AI mammography assistant that analyzes 2D and 3D mammograms to detect soft tissue lesions, masses, distortions, asymmetries, and microcalcifications with 85% sensitivity and 93% specificity for cancer detection.
  • Pixyl.Neuro.MS FDA-cleared and CE-marked AI solution for multiple sclerosis on brain MRI that automatically detects, categorizes, and quantifies white-matter lesions on 3D FLAIR, with 97% sensitivity for detecting disease activity.
  • Pixyl.Neuro.BV FDA-cleared and CE-marked AI solution that segments brain structures on 3D T1-weighted MRI, computes volumes, compares to a normative population, and highlights atrophy patterns for Alzheimer's disease and other dementias.
  • LumbarMR AI solution for lumbar spine MRI that automatically detects and characterizes degenerative findings including endplate degeneration, disc herniation, compression fractures, spondylolisthesis, central canal stenosis, foraminal stenosis, and facet arthropathy.
  • Voice AI-powered voice dictation and reporting assistant that listens to radiologist dictation, understands medical context, auto-fills indication, technique, and findings, and proposes smart impressions across custom templates.
  • AutoReport AI reporting assistant that automatically generates structured radiology reports with AI findings, key measurements, and smart impressions, compatible with HL7, FHIR, and DICOM SR standards.

Quantifiable outcome

  • Missed fractures decreased by 30% with AI assistance
  • +6 more outcomes

Companies that use Gleamer

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles3 records

Gleamer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability9 records

Feature12 records

Gleamer partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, major and flagship.

  • PhilipscoreTechnology or Integration · 18 February 2026Vestre Viken Hospital Trust implemented Philips AI Manager with Philips Vue PACS, deploying Gleamer's BoneView as the first AI solution in routine clinical use. Demonstrates integration capabilities with Philips healthcare IT infrastructure.
  • Google CloudcoreTechnology or Integration · 22 December 2025Strategic partnership where Google Cloud powers Gleamer's radiological AI platform, Gleamer Copilot. Leverages Google Cloud infrastructure including BigQuery, Vertex AI, and Med-PaLM for automated diagnostic report generation. Platform deployed in 2,500+ institutions across 45 countries processing 35 million examinations annually.
  • France Imageries TerritoiresmajorStrategic or Co-development Partner · 9 July 2025Strategic partnership to deploy Gleamer Copilot nationwide across France Imageries Territoires imaging network. Major national deployment expanding Gleamer's presence in French healthcare market.
  • Konica Minolta HealthcarecoreTechnology or Integration · 4 December 2024Partnership to provide best-in-class AI-powered solution with Konica Minolta's portfolio of advanced X-ray systems. Combines Gleamer's AI detection capabilities with Konica Minolta's imaging hardware for integrated customer offerings.
  • Siemens HealthineerscoreTechnology or Integration · 6 September 2024Gleamer's BoneView available on Siemens Healthineers Digital Marketplace, enabling seamless integration with Siemens Healthineers PACS and imaging systems. Expands distribution through Siemens Healthineers global customer network.
  • Vestre Viken Hospital TrustflagshipImplementation/ SI/ Consulting Partner · 1 August 2023Norway's first hospital trust to integrate Philips AI Manager with Philips Vue PACS, deploying Gleamer's BoneView as first AI solution. Since August 2023, examined 74,000 patients, saving 594 days waiting time, preventing 13,800 emergency consultations, freeing 3,100 physician hours. Sets national blueprint for AI deployment in radiology.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Gleamer competitors and assessment

Company assessment

Direct peers

  • Aidoc: Aidoc is a direct competitor offering a comprehensive AI platform for radiology covering multiple modalities and clinical workflows, with FDA-cleared applications across CT, X-ray, and MRI. It targets the same hospital and imaging center buyer base as Gleamer with a similar platform-plus-app strategy.
  • Qure.ai: Qure.ai develops multi-modality radiology AI (chest X-ray, head CT, lung nodule, musculoskeletal) with strong presence in emerging and developed markets. It competes head-to-head with Gleamer in fracture, chest, and head CT detection products sold to hospitals and radiology groups.
  • Lunit: Lunit is a publicly-traded Korean radiology AI company known for its chest X-ray (Lunit INSIGHT CXR) and mammography (Lunit INSIGHT MMG) products. It directly competes with Gleamer's ChestView and BreastView in the mammography and chest X-ray detection categories.
  • Annalise.ai: Annalise.ai offers a comprehensive AI decision-support platform covering X-ray and CT findings across multiple anatomies, with broad modality coverage that mirrors Gleamer Copilot's horizontal strategy. It serves hospitals and radiology groups globally with a similar product breadth.
  • Viz.ai: Viz.ai is a leading AI platform for time-sensitive radiology workflows, particularly stroke and cardiology, selling into the same hospital system buyer base as Gleamer. It represents a strong AI-native peer in adjacent clinical use cases within the radiology AI category.
  • RapidAI: RapidAI provides AI-driven imaging analysis for stroke, aneurysm, and other time-sensitive conditions, with hospital enterprise sales. It overlaps with Gleamer's MRI/CT product strategy in neurovascular and shares the same hospital radiology buyer.

Broad incumbents

  • Siemens Healthineers (AI-Rad Companion): Siemens Healthineers is both a Gleamer partner (Digital Marketplace) and a competitor via its AI-Rad Companion portfolio, which offers native radiology AI capabilities to its large installed base of imaging systems. It represents a broad incumbent with overlapping capabilities but a much wider portfolio.
  • Philips (AI Manager / AI portfolio): Philips is both a Gleamer partner (AI Manager integration at Vestre Viken) and a competitor through its broader clinical AI portfolio tied to Vue PACS and imaging systems. It has the scale and distribution to bundle first-party AI offerings alongside Gleamer's solutions.
  • GE HealthCare (Edison AI): GE HealthCare competes through its Edison AI platform and AI-powered imaging applications integrated with its large installed base of CT, MRI, and X-ray systems. It is a broad incumbent with the scale to bundle or replace third-party AI solutions like Gleamer's.

Emerging players

  • Riverain Technologies: Riverain Technologies is a focused radiology AI company specializing in chest X-ray interpretation, directly competing with Gleamer's ChestView in the same clinical use case. It is a smaller, more focused player with partial modality overlap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Gleamer social profiles

Digital presence

Gleamer compliance and trust

Trust signal

Compliance12 records

Gleamer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gleamer leadership team

Management profile

Number of profiles

Profiles3 records

Gleamer subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Gleamer funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gleamer M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gleamer

What does Gleamer do?

Gleamer develops and sells AI-powered clinical software for radiologists that detects fractures, chest pathologies, lung nodules, breast lesions, and neurological findings on X-ray, CT, MRI, and mammography images, automates musculoskeletal measurements, and generates structured radiology reports. Its Gleamer Copilot platform unifies these AI applications and integrates them into radiologist PACS/RIS workflows through the GleamerOS orchestration layer.

Is Gleamer a public or private company?

Gleamer is a private company. It is classified as corporate owned and is currently acquired.

When was Gleamer founded?

Gleamer was founded in 2017. It employs 101 to 250 people.

Where is Gleamer based?

Gleamer is headquartered in Paris, France, in the Europe region.

How does Gleamer make money?

One revenue line is on record: saaS Subscriptions.

Who are Gleamer's main competitors?

Direct peers on record are Aidoc, Qure.ai, Lunit, Annalise.ai, Viz.ai and RapidAI. Broad incumbents are Siemens Healthineers (AI-Rad Companion), Philips (AI Manager / AI portfolio) and GE HealthCare (Edison AI). Riverain Technologies is listed as an emerging player.

Does Gleamer have an API?

No public API is recorded for Gleamer.

What industry is Gleamer in?

Gleamer's product category is Radiology AI / Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 54151 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startup BusinessDalla diagnosi alla refertazione, cambia il percorso della RadiologiaDeepHealth will showcase its expanded AI radiology portfolio at the SIRM congress in Milan, integrating French firm Gleamer. The portfolio supports over 40 million AI-assisted diagnoses annually across 1,800 centers, with about five million in Italy. It also introduces TechLive for remote imaging.PR NewswireMedical Image Analysis Software Market worth $6.42 billion by 2031 - Exclusive Report by MarketsandMarkets™The medical image analysis software market is projected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, an 8.1% CAGR. North America held the largest regional share at 38.4% in 2025, and the integrated software segment accounted for 64.5% of the market. AI-enabled technology is expected to see the fastest growth at 8.6% CAGR.NewswireCardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial FrontsVentripoint Diagnostics submitted its VMS+ 4.0 AI cardiac imaging system to China's NMPA for approval and will exhibit at the AEPC congress in Padua. The company also signed a commercial agreement with LG Consulting Solutions for Northern California hospital deployments. The NMPA review is underway, with further updates expected.GlobeNewswireRadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash FlowRadNet reported Q1 2026 revenue of $575.6 million, up 22.1% year-over-year, and adjusted EBITDA of $63.3 million, up 36.3%. The company revised its 2026 Imaging Center guidance upward for revenue, adjusted EBITDA, and free cash flow, citing strong rebound after winter weather impacts.CB InsightsState of Digital Health Q1’26Digital health funding reached $7.4B in Q1'26, up from $5.9B, with mega-rounds capturing 60% of capital. M&A deals rose 47% to 56, led by Abbott's $23B Exact Sciences acquisition. Prior authorization mandates and AI drug discovery investments are expected to intensify consolidation in 2026.Signify ResearchMedical Imaging AI: Key Acquisitions, Partnerships & FDA Breakthrough UpdatesMarch 2026 saw continued momentum across medical imaging AI at ECR, with consolidation through M&A, platform ecosystem expansion, and deeper integration of AI into imaging IT infrastructure. Key acquisitions included RadNet's purchase of Gleamer for up to €230 million and Sectra's acquisition of Oxipit, while Medimaps Group and Radiobotics announced a strategic merger to combine MSK imaging AI portfolios. On the regulatory front, Harrison.ai received FDA 510(k) clearance for acute infarct triage on non-contrast CT brain scans, and Radiology Partners secured FDA Breakthrough Device designation for its generative AI chest X-ray solution.YahooRadNet Deepens AI Ambitions With Gleamer Deal And Workflow FocusRadNet has acquired Paris-based Gleamer SAS, a radiology AI company with FDA-cleared imaging tools, for up to €230 million, expanding its DeepHealth subsidiary into what the company describes as the world's largest radiology AI provider by clinical breadth. The deal integrates Gleamer's FDA-cleared X-ray and musculoskeletal tools into RadNet's existing imaging workflows alongside previous acquisitions like iCAD and See-Mode. The acquisition pushes RadNet further into AI-powered imaging services, with the goal of building a single integrated AI layer across mammography, CT, MRI, X-ray, and ultrasound modalities, though it also adds integration complexity and execution risk.Tech TimesHow Top Medical AI Tools for Radiology Imaging with Aidoc Arterys and Gleamer Triage and FlagsThis article is an educational feature examining how AI radiology tools from Aidoc, Arterys, and Gleamer are being integrated into healthcare workflows to help clinicians triage imaging studies, flag urgent findings, and manage increasing scan volumes. Each platform targets different aspects of radiology: Aidoc focuses on acute triage and emergency detection across CT scans, Arterys provides cloud-based visualization and quantification for cardiology and oncology, and Gleamer specializes in X-ray analysis for trauma and musculoskeletal imaging. The piece describes these tools as complementary solutions that integrate with existing PACS systems to reduce radiologist workload and improve detection accuracy, rather than replacing human expertise.YahooRadNet (RDNT) Acquires Gleamer for €230 MillionRadNet, Inc. announced the acquisition of Paris-based Gleamer SAS for up to €230 million on March 2, 2026, structured as an all-cash transaction. The deal positions RadNet's subsidiary DeepHealth as the world's largest radiology AI provider, integrating Gleamer's FDA-cleared X-ray and musculoskeletal AI into its portfolio alongside solutions for MR, CT, Ultrasound, and Mammography. Gleamer reported 90% ARR growth between 2022 and 2025 and is expected to reach $30 million in ARR by 2026, serving 700 global contracts.Simply Wall StRadNet’s Gleamer Deal And Short Seller Questions Reshape AI ThesisRadNet announced plans to acquire AI medical imaging firm Gleamer for nearly US$270 million, expanding its AI capabilities within its core radiology services business. The deal has sparked investor debate over the price tag and strategic fit, compounded by a short-seller report questioning RadNet's accounting methodology and key performance metrics. The simultaneous arrival of the acquisition announcement and short-seller critique has placed additional scrutiny on RadNet's balance sheet, capital allocation, and disclosure practices.